There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TG Therapeutics (NASDAQ: TGTX) and Cytokinetics Inc (NASDAQ: CYTK) with bullish sentiments.
TG Therapeutics (NASDAQ: TGTX)
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on TG Therapeutics (NASDAQ: TGTX), with a price target of $38. The company’s shares closed on Friday at $13.70.
White commented:
“We believe MF represents another opportunity for umbralisib, especially given its safety profile and activity with Jakafi in ruxolitinib-experienced patients.”
According to TipRanks.com, White is a 5-star analyst with an average return of 26.6% and a 54.1% success rate. White covers the Healthcare sector, focusing on stocks such as Spectrum Pharmaceuticals, Synthetic Biologics Inc, and Karyopharm Therapeutics.
Currently, the analyst consensus on TG Therapeutics is Strong Buy and the average price target is $31.50, representing a 129.9% upside.
In a report issued on June 4, Raymond James also maintained a Buy rating on the stock.
See today’s analyst top recommended stocks >>
Cytokinetics Inc (NASDAQ: CYTK)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Cytokinetics Inc (NASDAQ: CYTK), with a price target of $24. The company’s shares closed on Friday at $9.90.
According to TipRanks.com, Pantginis is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -8.7% and a 37.4% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as SELLAS Life Sciences Group Inc, Applied Genetic Technologies, and Checkpoint Therapeutics Inc.
Currently, the analyst consensus on Cytokinetics Inc is Moderate Buy and the average price target is $14.33, representing a 44.7% upside.
In a report released today, Piper Jaffray also maintained a Buy rating on the stock with a $13 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CYTK:
